Celgene Corp (CELG)

CELG (NASDAQ:Drugs)
$103.24
pos +0.00
+0.00%
Today's Range: 99.21 - 103.31 | CELG Avg Daily Volume: 4,604,300
Last Update: 10/24/14 - 3:59 PM EDT
Volume: 0
YTD Performance: 22.20%
Open: $0.00
Previous Close: $100.40
52 Week Range: $66.85 - $103.31
Oustanding Shares: 799,510,100
Market Cap: 80,270,814,040
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 16 16 16
Moderate Buy 1 1 1 0
Hold 2 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.26 1.35 1.43 1.40
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 52.57
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
52.57 57.90 28.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
19.78% 30.72% 204.27%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.87 $n.a. $3.24 $4.38
Number of Analysts 4 0 1 4
High Estimate $0.91 $n.a. $3.24 $4.94
Low Estimate $0.85 $n.a. $3.24 $4.09
Prior Year $0.67 $0.73 $2.68 $3.24
Growth Rate (Year over Year) 31.20% n.a.% 20.90% 35.19%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Aiming a Shotgun at Biotech Real Money Pro($)

I invest in biotech in a different way than any other sector.

Celgene Price Bump Real Money Pro($)

From The Street of Dreams
Bullish
Oct 24, 2014 | 7:42 AM EDT
CELG price target raised to $134 from $115, said Deutsche. Company has emerged as having best pipeline in biotech group. Rating remains...
I could have selected several others as well.

This Morning's Market Setup Real Money Pro($)

Where it began.
Welcome back to the airlines and the biotechs.
Technical indicators have now swung in the bears' favor.
This group reminds us of our nation's innovative spirit and fabulous science.
The iShares Transportation Average (IYT) is one to watch.
Odds are up for an impending upward reversal.

Columnist Conversations

GS has cleared the important hurdle on the way up which increases the odds for an eventual rally towards the 1...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher. CLMS was up about ...
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sending the stock up about...
Market posting decent day considering Ebola getting headlines again. Believe investors have learned not to pa...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.